Global Recombinant Glycoproteins Supply, Demand and Key Producers, 2026-2032
The global Recombinant Glycoproteins market size is expected to reach $ 1535 million by 2032, rising at a market growth of 7.6% CAGR during the forecast period (2026-2032).
Recombinant Glycoproteins are protein products generated by recombinant genetic engineering and expressed in host systems capable of adding glycosylation modifications. They are commonly supplied as lyophilized powder, clear to slightly opalescent solution, frozen bulk drug substance, or process intermediates. Structurally, they consist of a defined polypeptide backbone and covalently attached glycans, including N-linked glycans, O-linked glycans, or engineered glycoforms. Major product categories include monoclonal antibodies, fusion proteins, glycoprotein hormones, cytokines, enzymes, coagulation or complement-related proteins, and viral surface glycoproteins. Their manufacturing requires stringent control of expression host selection, cell-line development, culture conditions, purification, glycan consistency, host-cell impurities, residual DNA, and batch-to-batch stability. Recombinant Glycoproteins are used in therapeutic biologics, biosimilars, vaccine antigens, in vitro diagnostics, drug discovery, basic research, and biomanufacturing quality control.
The market expansion is mainly driven by the upgrading of biologics manufacturing, biosimilar substitution after patent expirations, and higher quality expectations for complex protein therapeutics. Glycan structures influence receptor binding, in vivo stability, clearance, and immune-related functions, making this product group strategically important in monoclonal antibodies, fusion proteins, glycoprotein hormones, and enzyme replacement therapies. As high-yield cell lines, continuous biomanufacturing, glycoengineering, mass-spectrometry-based characterization, and automated scale-up become more mature, manufacturers are better positioned to control glycoform distribution, batch consistency, and commercial production efficiency.
The main constraints are concentrated in development complexity, manufacturing control, and regulatory requirements. Recombinant Glycoproteins are not simple copies of amino acid sequences; their glycosylation patterns are host-dependent and process-sensitive. Culture media, cell status, bioreactor parameters, purification steps, and storage conditions can all affect the final glycan profile. For biosimilar developers, matching the reference product?s glycoforms, managing immunogenicity risk, proving comparability, scaling production, and competing on price remain major barriers. For research reagent suppliers, commoditized catalog products, insufficient quality validation, batch variation, and channel competition can weaken pricing power.
Downstream demand is shifting toward high-quality, verifiable, traceable, and customized products. Pharmaceutical companies require stable supply systems that can support clinical and commercial production. Diagnostic companies need antigens and controls with low batch variability and stable bioactivity. Research users increasingly evaluate expression systems, glycan profiling, purity, endotoxin level, aggregation status, and functional activity data. Faster-growing demand is expected from antibody and fusion-protein biosimilars, viral glycoprotein antigens, complex disease diagnostics, cell-therapy research support, glycoengineered proteins, and premium custom expression services.
This report studies the global Recombinant Glycoproteins production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Glycoproteins and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Glycoproteins that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Glycoproteins total production and demand, 2021-2032, (MT)
Global Recombinant Glycoproteins total production value, 2021-2032, (USD Million)
Global Recombinant Glycoproteins production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Recombinant Glycoproteins consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Recombinant Glycoproteins domestic production, consumption, key domestic manufacturers and share
Global Recombinant Glycoproteins production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Recombinant Glycoproteins production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Recombinant Glycoproteins production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Recombinant Glycoproteins market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Novartis, Johnson & Johnson, Merck, AstraZeneca, Sanofi, Bristol Myers Squibb, Amgen, Regeneron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Glycoproteins market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Recombinant Glycoproteins Market, By Region:
1. How big is the global Recombinant Glycoproteins market?
2. What is the demand of the global Recombinant Glycoproteins market?
3. What is the year over year growth of the global Recombinant Glycoproteins market?
4. What is the production and production value of the global Recombinant Glycoproteins market?
5. Who are the key producers in the global Recombinant Glycoproteins market?
6. What are the growth factors driving the market demand?
Recombinant Glycoproteins are protein products generated by recombinant genetic engineering and expressed in host systems capable of adding glycosylation modifications. They are commonly supplied as lyophilized powder, clear to slightly opalescent solution, frozen bulk drug substance, or process intermediates. Structurally, they consist of a defined polypeptide backbone and covalently attached glycans, including N-linked glycans, O-linked glycans, or engineered glycoforms. Major product categories include monoclonal antibodies, fusion proteins, glycoprotein hormones, cytokines, enzymes, coagulation or complement-related proteins, and viral surface glycoproteins. Their manufacturing requires stringent control of expression host selection, cell-line development, culture conditions, purification, glycan consistency, host-cell impurities, residual DNA, and batch-to-batch stability. Recombinant Glycoproteins are used in therapeutic biologics, biosimilars, vaccine antigens, in vitro diagnostics, drug discovery, basic research, and biomanufacturing quality control.
The market expansion is mainly driven by the upgrading of biologics manufacturing, biosimilar substitution after patent expirations, and higher quality expectations for complex protein therapeutics. Glycan structures influence receptor binding, in vivo stability, clearance, and immune-related functions, making this product group strategically important in monoclonal antibodies, fusion proteins, glycoprotein hormones, and enzyme replacement therapies. As high-yield cell lines, continuous biomanufacturing, glycoengineering, mass-spectrometry-based characterization, and automated scale-up become more mature, manufacturers are better positioned to control glycoform distribution, batch consistency, and commercial production efficiency.
The main constraints are concentrated in development complexity, manufacturing control, and regulatory requirements. Recombinant Glycoproteins are not simple copies of amino acid sequences; their glycosylation patterns are host-dependent and process-sensitive. Culture media, cell status, bioreactor parameters, purification steps, and storage conditions can all affect the final glycan profile. For biosimilar developers, matching the reference product?s glycoforms, managing immunogenicity risk, proving comparability, scaling production, and competing on price remain major barriers. For research reagent suppliers, commoditized catalog products, insufficient quality validation, batch variation, and channel competition can weaken pricing power.
Downstream demand is shifting toward high-quality, verifiable, traceable, and customized products. Pharmaceutical companies require stable supply systems that can support clinical and commercial production. Diagnostic companies need antigens and controls with low batch variability and stable bioactivity. Research users increasingly evaluate expression systems, glycan profiling, purity, endotoxin level, aggregation status, and functional activity data. Faster-growing demand is expected from antibody and fusion-protein biosimilars, viral glycoprotein antigens, complex disease diagnostics, cell-therapy research support, glycoengineered proteins, and premium custom expression services.
This report studies the global Recombinant Glycoproteins production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Glycoproteins and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Glycoproteins that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Glycoproteins total production and demand, 2021-2032, (MT)
Global Recombinant Glycoproteins total production value, 2021-2032, (USD Million)
Global Recombinant Glycoproteins production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Recombinant Glycoproteins consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Recombinant Glycoproteins domestic production, consumption, key domestic manufacturers and share
Global Recombinant Glycoproteins production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Recombinant Glycoproteins production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Recombinant Glycoproteins production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Recombinant Glycoproteins market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Novartis, Johnson & Johnson, Merck, AstraZeneca, Sanofi, Bristol Myers Squibb, Amgen, Regeneron, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Glycoproteins market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (USD/MT) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Recombinant Glycoproteins Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monoclonal Antibodies
- Fc Fusion Proteins
- Glycoprotein Hormones
- Enzyme Replacement Proteins
- Viral Glycoproteins
- Others
- Mammalian Cell Expression
- Yeast Expression
- Insect Cell Expression
- Others
- Lyophilized Powder
- Liquid Solution
- Frozen Bulk Protein
- Formulated Drug Product
- N-Linked Glycoproteins
- O-Linked Glycoproteins
- Mixed N- and O-Linked Glycoproteins
- Blood & Oncology Diseases
- Chronic Diseases
- Others
- Roche
- Pfizer
- Novartis
- Johnson & Johnson
- Merck
- AstraZeneca
- Sanofi
- Bristol Myers Squibb
- Amgen
- Regeneron
- Sandoz
- Teva
- Fresenius Kabi
- STADA
- Biogen
- Celltrion
- Samsung Bioepis
- Samsung Biologics
- Biocon
- Intas
- Dr. Reddy?s
- Apotex
- Alvotech
- Coherus
- Boehringer Ingelheim
- Lonza
- FUJIFILM Diosynth Biotechnologies
- WuXi Biologics
- Bio-Thera Solutions
- Henlius
- Innovent Biologics
- Hengrui Pharmaceutical
- Junshi Biosciences
- Sino Biological
- ACROBiosystems
- GenScript
- Bio-Techne
- Takeda
- Kyowa Kirin
- Daiichi Sankyo
1. How big is the global Recombinant Glycoproteins market?
2. What is the demand of the global Recombinant Glycoproteins market?
3. What is the year over year growth of the global Recombinant Glycoproteins market?
4. What is the production and production value of the global Recombinant Glycoproteins market?
5. Who are the key producers in the global Recombinant Glycoproteins market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Recombinant Glycoproteins Introduction
1.2 World Recombinant Glycoproteins Supply & Forecast
1.2.1 World Recombinant Glycoproteins Production Value (2021 & 2025 & 2032)
1.2.2 World Recombinant Glycoproteins Production (2021-2032)
1.2.3 World Recombinant Glycoproteins Pricing Trends (2021-2032)
1.3 World Recombinant Glycoproteins Production by Region (Based on Production Site)
1.3.1 World Recombinant Glycoproteins Production Value by Region (2021-2032)
1.3.2 World Recombinant Glycoproteins Production by Region (2021-2032)
1.3.3 World Recombinant Glycoproteins Average Price by Region (2021-2032)
1.3.4 North America Recombinant Glycoproteins Production (2021-2032)
1.3.5 Europe Recombinant Glycoproteins Production (2021-2032)
1.3.6 China Recombinant Glycoproteins Production (2021-2032)
1.3.7 Japan Recombinant Glycoproteins Production (2021-2032)
1.3.8 South Korea Recombinant Glycoproteins Production (2021-2032)
1.3.9 India Recombinant Glycoproteins Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Glycoproteins Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Glycoproteins Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant Glycoproteins Demand (2021-2032)
2.2 World Recombinant Glycoproteins Consumption by Region
2.2.1 World Recombinant Glycoproteins Consumption by Region (2021-2026)
2.2.2 World Recombinant Glycoproteins Consumption Forecast by Region (2027-2032)
2.3 United States Recombinant Glycoproteins Consumption (2021-2032)
2.4 China Recombinant Glycoproteins Consumption (2021-2032)
2.5 Europe Recombinant Glycoproteins Consumption (2021-2032)
2.6 Japan Recombinant Glycoproteins Consumption (2021-2032)
2.7 South Korea Recombinant Glycoproteins Consumption (2021-2032)
2.8 ASEAN Recombinant Glycoproteins Consumption (2021-2032)
2.9 India Recombinant Glycoproteins Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Glycoproteins Production Value by Manufacturer (2021-2026)
3.2 World Recombinant Glycoproteins Production by Manufacturer (2021-2026)
3.3 World Recombinant Glycoproteins Average Price by Manufacturer (2021-2026)
3.4 Recombinant Glycoproteins Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Glycoproteins Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Glycoproteins in 2025
3.5.3 Global Concentration Ratios (CR8) for Recombinant Glycoproteins in 2025
3.6 Recombinant Glycoproteins Market: Overall Company Footprint Analysis
3.6.1 Recombinant Glycoproteins Market: Region Footprint
3.6.2 Recombinant Glycoproteins Market: Company Product Type Footprint
3.6.3 Recombinant Glycoproteins Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Glycoproteins Production Value Comparison
4.1.1 United States VS China: Recombinant Glycoproteins Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Recombinant Glycoproteins Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Recombinant Glycoproteins Production Comparison
4.2.1 United States VS China: Recombinant Glycoproteins Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Recombinant Glycoproteins Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Recombinant Glycoproteins Consumption Comparison
4.3.1 United States VS China: Recombinant Glycoproteins Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Recombinant Glycoproteins Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Recombinant Glycoproteins Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Glycoproteins Production Value (2021-2026)
4.4.3 United States Based Manufacturers Recombinant Glycoproteins Production (2021-2026)
4.5 China Based Recombinant Glycoproteins Manufacturers and Market Share
4.5.1 China Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Glycoproteins Production Value (2021-2026)
4.5.3 China Based Manufacturers Recombinant Glycoproteins Production (2021-2026)
4.6 Rest of World Based Recombinant Glycoproteins Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Glycoproteins Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Recombinant Glycoproteins Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Glycoproteins Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 Fc Fusion Proteins
5.2.3 Glycoprotein Hormones
5.2.4 Enzyme Replacement Proteins
5.2.5 Viral Glycoproteins
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Recombinant Glycoproteins Production by Type (2021-2032)
5.3.2 World Recombinant Glycoproteins Production Value by Type (2021-2032)
5.3.3 World Recombinant Glycoproteins Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY EXPRESSION SYSTEM
6.1 World Recombinant Glycoproteins Market Size Overview by Expression System: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Expression System
6.2.1 Mammalian Cell Expression
6.2.2 Yeast Expression
6.2.3 Insect Cell Expression
6.2.4 Others
6.3 Market Segment by Expression System
6.3.1 World Recombinant Glycoproteins Production by Expression System (2021-2032)
6.3.2 World Recombinant Glycoproteins Production Value by Expression System (2021-2032)
6.3.3 World Recombinant Glycoproteins Average Price by Expression System (2021-2032)
7 MARKET ANALYSIS BY PRODUCT FORM
7.1 World Recombinant Glycoproteins Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
7.2.1 Lyophilized Powder
7.2.2 Liquid Solution
7.2.3 Frozen Bulk Protein
7.2.4 Formulated Drug Product
7.3 Market Segment by Product Form
7.3.1 World Recombinant Glycoproteins Production by Product Form (2021-2032)
7.3.2 World Recombinant Glycoproteins Production Value by Product Form (2021-2032)
7.3.3 World Recombinant Glycoproteins Average Price by Product Form (2021-2032)
8 MARKET ANALYSIS BY GLYCOSYLATION TYPE
8.1 World Recombinant Glycoproteins Market Size Overview by Glycosylation Type: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Glycosylation Type
8.2.1 N-Linked Glycoproteins
8.2.2 O-Linked Glycoproteins
8.2.3 Mixed N- and O-Linked Glycoproteins
8.3 Market Segment by Glycosylation Type
8.3.1 World Recombinant Glycoproteins Production by Glycosylation Type (2021-2032)
8.3.2 World Recombinant Glycoproteins Production Value by Glycosylation Type (2021-2032)
8.3.3 World Recombinant Glycoproteins Average Price by Glycosylation Type (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Recombinant Glycoproteins Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Blood & Oncology Diseases
9.2.2 Chronic Diseases
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Recombinant Glycoproteins Production by Application (2021-2032)
9.3.2 World Recombinant Glycoproteins Production Value by Application (2021-2032)
9.3.3 World Recombinant Glycoproteins Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Roche
10.1.1 Roche Details
10.1.2 Roche Major Business
10.1.3 Roche Recombinant Glycoproteins Product and Services
10.1.4 Roche Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Roche Recent Developments/Updates
10.1.6 Roche Competitive Strengths & Weaknesses
10.2 Pfizer
10.2.1 Pfizer Details
10.2.2 Pfizer Major Business
10.2.3 Pfizer Recombinant Glycoproteins Product and Services
10.2.4 Pfizer Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Pfizer Recent Developments/Updates
10.2.6 Pfizer Competitive Strengths & Weaknesses
10.3 Novartis
10.3.1 Novartis Details
10.3.2 Novartis Major Business
10.3.3 Novartis Recombinant Glycoproteins Product and Services
10.3.4 Novartis Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Novartis Recent Developments/Updates
10.3.6 Novartis Competitive Strengths & Weaknesses
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Details
10.4.2 Johnson & Johnson Major Business
10.4.3 Johnson & Johnson Recombinant Glycoproteins Product and Services
10.4.4 Johnson & Johnson Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Johnson & Johnson Recent Developments/Updates
10.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
10.5 Merck
10.5.1 Merck Details
10.5.2 Merck Major Business
10.5.3 Merck Recombinant Glycoproteins Product and Services
10.5.4 Merck Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Merck Recent Developments/Updates
10.5.6 Merck Competitive Strengths & Weaknesses
10.6 AstraZeneca
10.6.1 AstraZeneca Details
10.6.2 AstraZeneca Major Business
10.6.3 AstraZeneca Recombinant Glycoproteins Product and Services
10.6.4 AstraZeneca Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 AstraZeneca Recent Developments/Updates
10.6.6 AstraZeneca Competitive Strengths & Weaknesses
10.7 Sanofi
10.7.1 Sanofi Details
10.7.2 Sanofi Major Business
10.7.3 Sanofi Recombinant Glycoproteins Product and Services
10.7.4 Sanofi Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Sanofi Recent Developments/Updates
10.7.6 Sanofi Competitive Strengths & Weaknesses
10.8 Bristol Myers Squibb
10.8.1 Bristol Myers Squibb Details
10.8.2 Bristol Myers Squibb Major Business
10.8.3 Bristol Myers Squibb Recombinant Glycoproteins Product and Services
10.8.4 Bristol Myers Squibb Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Bristol Myers Squibb Recent Developments/Updates
10.8.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
10.9 Amgen
10.9.1 Amgen Details
10.9.2 Amgen Major Business
10.9.3 Amgen Recombinant Glycoproteins Product and Services
10.9.4 Amgen Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Amgen Recent Developments/Updates
10.9.6 Amgen Competitive Strengths & Weaknesses
10.10 Regeneron
10.10.1 Regeneron Details
10.10.2 Regeneron Major Business
10.10.3 Regeneron Recombinant Glycoproteins Product and Services
10.10.4 Regeneron Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Regeneron Recent Developments/Updates
10.10.6 Regeneron Competitive Strengths & Weaknesses
10.11 Sandoz
10.11.1 Sandoz Details
10.11.2 Sandoz Major Business
10.11.3 Sandoz Recombinant Glycoproteins Product and Services
10.11.4 Sandoz Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 Sandoz Recent Developments/Updates
10.11.6 Sandoz Competitive Strengths & Weaknesses
10.12 Teva
10.12.1 Teva Details
10.12.2 Teva Major Business
10.12.3 Teva Recombinant Glycoproteins Product and Services
10.12.4 Teva Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.12.5 Teva Recent Developments/Updates
10.12.6 Teva Competitive Strengths & Weaknesses
10.13 Fresenius Kabi
10.13.1 Fresenius Kabi Details
10.13.2 Fresenius Kabi Major Business
10.13.3 Fresenius Kabi Recombinant Glycoproteins Product and Services
10.13.4 Fresenius Kabi Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.13.5 Fresenius Kabi Recent Developments/Updates
10.13.6 Fresenius Kabi Competitive Strengths & Weaknesses
10.14 STADA
10.14.1 STADA Details
10.14.2 STADA Major Business
10.14.3 STADA Recombinant Glycoproteins Product and Services
10.14.4 STADA Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.14.5 STADA Recent Developments/Updates
10.14.6 STADA Competitive Strengths & Weaknesses
10.15 Biogen
10.15.1 Biogen Details
10.15.2 Biogen Major Business
10.15.3 Biogen Recombinant Glycoproteins Product and Services
10.15.4 Biogen Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.15.5 Biogen Recent Developments/Updates
10.15.6 Biogen Competitive Strengths & Weaknesses
10.16 Celltrion
10.16.1 Celltrion Details
10.16.2 Celltrion Major Business
10.16.3 Celltrion Recombinant Glycoproteins Product and Services
10.16.4 Celltrion Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.16.5 Celltrion Recent Developments/Updates
10.16.6 Celltrion Competitive Strengths & Weaknesses
10.17 Samsung Bioepis
10.17.1 Samsung Bioepis Details
10.17.2 Samsung Bioepis Major Business
10.17.3 Samsung Bioepis Recombinant Glycoproteins Product and Services
10.17.4 Samsung Bioepis Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.17.5 Samsung Bioepis Recent Developments/Updates
10.17.6 Samsung Bioepis Competitive Strengths & Weaknesses
10.18 Samsung Biologics
10.18.1 Samsung Biologics Details
10.18.2 Samsung Biologics Major Business
10.18.3 Samsung Biologics Recombinant Glycoproteins Product and Services
10.18.4 Samsung Biologics Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.18.5 Samsung Biologics Recent Developments/Updates
10.18.6 Samsung Biologics Competitive Strengths & Weaknesses
10.19 Biocon
10.19.1 Biocon Details
10.19.2 Biocon Major Business
10.19.3 Biocon Recombinant Glycoproteins Product and Services
10.19.4 Biocon Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.19.5 Biocon Recent Developments/Updates
10.19.6 Biocon Competitive Strengths & Weaknesses
10.20 Intas
10.20.1 Intas Details
10.20.2 Intas Major Business
10.20.3 Intas Recombinant Glycoproteins Product and Services
10.20.4 Intas Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.20.5 Intas Recent Developments/Updates
10.20.6 Intas Competitive Strengths & Weaknesses
10.21 Dr. Reddy?s
10.21.1 Dr. Reddy?s Details
10.21.2 Dr. Reddy?s Major Business
10.21.3 Dr. Reddy?s Recombinant Glycoproteins Product and Services
10.21.4 Dr. Reddy?s Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.21.5 Dr. Reddy?s Recent Developments/Updates
10.21.6 Dr. Reddy?s Competitive Strengths & Weaknesses
10.22 Apotex
10.22.1 Apotex Details
10.22.2 Apotex Major Business
10.22.3 Apotex Recombinant Glycoproteins Product and Services
10.22.4 Apotex Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.22.5 Apotex Recent Developments/Updates
10.22.6 Apotex Competitive Strengths & Weaknesses
10.23 Alvotech
10.23.1 Alvotech Details
10.23.2 Alvotech Major Business
10.23.3 Alvotech Recombinant Glycoproteins Product and Services
10.23.4 Alvotech Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.23.5 Alvotech Recent Developments/Updates
10.23.6 Alvotech Competitive Strengths & Weaknesses
10.24 Coherus
10.24.1 Coherus Details
10.24.2 Coherus Major Business
10.24.3 Coherus Recombinant Glycoproteins Product and Services
10.24.4 Coherus Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.24.5 Coherus Recent Developments/Updates
10.24.6 Coherus Competitive Strengths & Weaknesses
10.25 Boehringer Ingelheim
10.25.1 Boehringer Ingelheim Details
10.25.2 Boehringer Ingelheim Major Business
10.25.3 Boehringer Ingelheim Recombinant Glycoproteins Product and Services
10.25.4 Boehringer Ingelheim Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.25.5 Boehringer Ingelheim Recent Developments/Updates
10.25.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
10.26 Lonza
10.26.1 Lonza Details
10.26.2 Lonza Major Business
10.26.3 Lonza Recombinant Glycoproteins Product and Services
10.26.4 Lonza Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.26.5 Lonza Recent Developments/Updates
10.26.6 Lonza Competitive Strengths & Weaknesses
10.27 FUJIFILM Diosynth Biotechnologies
10.27.1 FUJIFILM Diosynth Biotechnologies Details
10.27.2 FUJIFILM Diosynth Biotechnologies Major Business
10.27.3 FUJIFILM Diosynth Biotechnologies Recombinant Glycoproteins Product and Services
10.27.4 FUJIFILM Diosynth Biotechnologies Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.27.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
10.27.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
10.28 WuXi Biologics
10.28.1 WuXi Biologics Details
10.28.2 WuXi Biologics Major Business
10.28.3 WuXi Biologics Recombinant Glycoproteins Product and Services
10.28.4 WuXi Biologics Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.28.5 WuXi Biologics Recent Developments/Updates
10.28.6 WuXi Biologics Competitive Strengths & Weaknesses
10.29 Bio-Thera Solutions
10.29.1 Bio-Thera Solutions Details
10.29.2 Bio-Thera Solutions Major Business
10.29.3 Bio-Thera Solutions Recombinant Glycoproteins Product and Services
10.29.4 Bio-Thera Solutions Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.29.5 Bio-Thera Solutions Recent Developments/Updates
10.29.6 Bio-Thera Solutions Competitive Strengths & Weaknesses
10.30 Henlius
10.30.1 Henlius Details
10.30.2 Henlius Major Business
10.30.3 Henlius Recombinant Glycoproteins Product and Services
10.30.4 Henlius Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.30.5 Henlius Recent Developments/Updates
10.30.6 Henlius Competitive Strengths & Weaknesses
10.31 Innovent Biologics
10.31.1 Innovent Biologics Details
10.31.2 Innovent Biologics Major Business
10.31.3 Innovent Biologics Recombinant Glycoproteins Product and Services
10.31.4 Innovent Biologics Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.31.5 Innovent Biologics Recent Developments/Updates
10.31.6 Innovent Biologics Competitive Strengths & Weaknesses
10.32 Hengrui Pharmaceutical
10.32.1 Hengrui Pharmaceutical Details
10.32.2 Hengrui Pharmaceutical Major Business
10.32.3 Hengrui Pharmaceutical Recombinant Glycoproteins Product and Services
10.32.4 Hengrui Pharmaceutical Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.32.5 Hengrui Pharmaceutical Recent Developments/Updates
10.32.6 Hengrui Pharmaceutical Competitive Strengths & Weaknesses
10.33 Junshi Biosciences
10.33.1 Junshi Biosciences Details
10.33.2 Junshi Biosciences Major Business
10.33.3 Junshi Biosciences Recombinant Glycoproteins Product and Services
10.33.4 Junshi Biosciences Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.33.5 Junshi Biosciences Recent Developments/Updates
10.33.6 Junshi Biosciences Competitive Strengths & Weaknesses
10.34 Sino Biological
10.34.1 Sino Biological Details
10.34.2 Sino Biological Major Business
10.34.3 Sino Biological Recombinant Glycoproteins Product and Services
10.34.4 Sino Biological Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.34.5 Sino Biological Recent Developments/Updates
10.34.6 Sino Biological Competitive Strengths & Weaknesses
10.35 ACROBiosystems
10.35.1 ACROBiosystems Details
10.35.2 ACROBiosystems Major Business
10.35.3 ACROBiosystems Recombinant Glycoproteins Product and Services
10.35.4 ACROBiosystems Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.35.5 ACROBiosystems Recent Developments/Updates
10.35.6 ACROBiosystems Competitive Strengths & Weaknesses
10.36 GenScript
10.36.1 GenScript Details
10.36.2 GenScript Major Business
10.36.3 GenScript Recombinant Glycoproteins Product and Services
10.36.4 GenScript Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.36.5 GenScript Recent Developments/Updates
10.36.6 GenScript Competitive Strengths & Weaknesses
10.37 Bio-Techne
10.37.1 Bio-Techne Details
10.37.2 Bio-Techne Major Business
10.37.3 Bio-Techne Recombinant Glycoproteins Product and Services
10.37.4 Bio-Techne Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.37.5 Bio-Techne Recent Developments/Updates
10.37.6 Bio-Techne Competitive Strengths & Weaknesses
10.38 Takeda
10.38.1 Takeda Details
10.38.2 Takeda Major Business
10.38.3 Takeda Recombinant Glycoproteins Product and Services
10.38.4 Takeda Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.38.5 Takeda Recent Developments/Updates
10.38.6 Takeda Competitive Strengths & Weaknesses
10.39 Kyowa Kirin
10.39.1 Kyowa Kirin Details
10.39.2 Kyowa Kirin Major Business
10.39.3 Kyowa Kirin Recombinant Glycoproteins Product and Services
10.39.4 Kyowa Kirin Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.39.5 Kyowa Kirin Recent Developments/Updates
10.39.6 Kyowa Kirin Competitive Strengths & Weaknesses
10.40 Daiichi Sankyo
10.40.1 Daiichi Sankyo Details
10.40.2 Daiichi Sankyo Major Business
10.40.3 Daiichi Sankyo Recombinant Glycoproteins Product and Services
10.40.4 Daiichi Sankyo Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.40.5 Daiichi Sankyo Recent Developments/Updates
10.40.6 Daiichi Sankyo Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Recombinant Glycoproteins Industry Chain
11.2 Recombinant Glycoproteins Upstream Analysis
11.2.1 Recombinant Glycoproteins Core Raw Materials
11.2.2 Main Manufacturers of Recombinant Glycoproteins Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Recombinant Glycoproteins Production Mode
11.6 Recombinant Glycoproteins Procurement Model
11.7 Recombinant Glycoproteins Industry Sales Model and Sales Channels
11.7.1 Recombinant Glycoproteins Sales Model
11.7.2 Recombinant Glycoproteins Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Recombinant Glycoproteins Introduction
1.2 World Recombinant Glycoproteins Supply & Forecast
1.2.1 World Recombinant Glycoproteins Production Value (2021 & 2025 & 2032)
1.2.2 World Recombinant Glycoproteins Production (2021-2032)
1.2.3 World Recombinant Glycoproteins Pricing Trends (2021-2032)
1.3 World Recombinant Glycoproteins Production by Region (Based on Production Site)
1.3.1 World Recombinant Glycoproteins Production Value by Region (2021-2032)
1.3.2 World Recombinant Glycoproteins Production by Region (2021-2032)
1.3.3 World Recombinant Glycoproteins Average Price by Region (2021-2032)
1.3.4 North America Recombinant Glycoproteins Production (2021-2032)
1.3.5 Europe Recombinant Glycoproteins Production (2021-2032)
1.3.6 China Recombinant Glycoproteins Production (2021-2032)
1.3.7 Japan Recombinant Glycoproteins Production (2021-2032)
1.3.8 South Korea Recombinant Glycoproteins Production (2021-2032)
1.3.9 India Recombinant Glycoproteins Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Glycoproteins Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Glycoproteins Major Market Trends
2 DEMAND SUMMARY
2.1 World Recombinant Glycoproteins Demand (2021-2032)
2.2 World Recombinant Glycoproteins Consumption by Region
2.2.1 World Recombinant Glycoproteins Consumption by Region (2021-2026)
2.2.2 World Recombinant Glycoproteins Consumption Forecast by Region (2027-2032)
2.3 United States Recombinant Glycoproteins Consumption (2021-2032)
2.4 China Recombinant Glycoproteins Consumption (2021-2032)
2.5 Europe Recombinant Glycoproteins Consumption (2021-2032)
2.6 Japan Recombinant Glycoproteins Consumption (2021-2032)
2.7 South Korea Recombinant Glycoproteins Consumption (2021-2032)
2.8 ASEAN Recombinant Glycoproteins Consumption (2021-2032)
2.9 India Recombinant Glycoproteins Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Glycoproteins Production Value by Manufacturer (2021-2026)
3.2 World Recombinant Glycoproteins Production by Manufacturer (2021-2026)
3.3 World Recombinant Glycoproteins Average Price by Manufacturer (2021-2026)
3.4 Recombinant Glycoproteins Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Glycoproteins Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Glycoproteins in 2025
3.5.3 Global Concentration Ratios (CR8) for Recombinant Glycoproteins in 2025
3.6 Recombinant Glycoproteins Market: Overall Company Footprint Analysis
3.6.1 Recombinant Glycoproteins Market: Region Footprint
3.6.2 Recombinant Glycoproteins Market: Company Product Type Footprint
3.6.3 Recombinant Glycoproteins Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Glycoproteins Production Value Comparison
4.1.1 United States VS China: Recombinant Glycoproteins Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Recombinant Glycoproteins Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Recombinant Glycoproteins Production Comparison
4.2.1 United States VS China: Recombinant Glycoproteins Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Recombinant Glycoproteins Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Recombinant Glycoproteins Consumption Comparison
4.3.1 United States VS China: Recombinant Glycoproteins Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Recombinant Glycoproteins Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Recombinant Glycoproteins Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Glycoproteins Production Value (2021-2026)
4.4.3 United States Based Manufacturers Recombinant Glycoproteins Production (2021-2026)
4.5 China Based Recombinant Glycoproteins Manufacturers and Market Share
4.5.1 China Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Glycoproteins Production Value (2021-2026)
4.5.3 China Based Manufacturers Recombinant Glycoproteins Production (2021-2026)
4.6 Rest of World Based Recombinant Glycoproteins Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Glycoproteins Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Recombinant Glycoproteins Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Glycoproteins Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Monoclonal Antibodies
5.2.2 Fc Fusion Proteins
5.2.3 Glycoprotein Hormones
5.2.4 Enzyme Replacement Proteins
5.2.5 Viral Glycoproteins
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Recombinant Glycoproteins Production by Type (2021-2032)
5.3.2 World Recombinant Glycoproteins Production Value by Type (2021-2032)
5.3.3 World Recombinant Glycoproteins Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY EXPRESSION SYSTEM
6.1 World Recombinant Glycoproteins Market Size Overview by Expression System: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Expression System
6.2.1 Mammalian Cell Expression
6.2.2 Yeast Expression
6.2.3 Insect Cell Expression
6.2.4 Others
6.3 Market Segment by Expression System
6.3.1 World Recombinant Glycoproteins Production by Expression System (2021-2032)
6.3.2 World Recombinant Glycoproteins Production Value by Expression System (2021-2032)
6.3.3 World Recombinant Glycoproteins Average Price by Expression System (2021-2032)
7 MARKET ANALYSIS BY PRODUCT FORM
7.1 World Recombinant Glycoproteins Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
7.2.1 Lyophilized Powder
7.2.2 Liquid Solution
7.2.3 Frozen Bulk Protein
7.2.4 Formulated Drug Product
7.3 Market Segment by Product Form
7.3.1 World Recombinant Glycoproteins Production by Product Form (2021-2032)
7.3.2 World Recombinant Glycoproteins Production Value by Product Form (2021-2032)
7.3.3 World Recombinant Glycoproteins Average Price by Product Form (2021-2032)
8 MARKET ANALYSIS BY GLYCOSYLATION TYPE
8.1 World Recombinant Glycoproteins Market Size Overview by Glycosylation Type: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Glycosylation Type
8.2.1 N-Linked Glycoproteins
8.2.2 O-Linked Glycoproteins
8.2.3 Mixed N- and O-Linked Glycoproteins
8.3 Market Segment by Glycosylation Type
8.3.1 World Recombinant Glycoproteins Production by Glycosylation Type (2021-2032)
8.3.2 World Recombinant Glycoproteins Production Value by Glycosylation Type (2021-2032)
8.3.3 World Recombinant Glycoproteins Average Price by Glycosylation Type (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Recombinant Glycoproteins Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Blood & Oncology Diseases
9.2.2 Chronic Diseases
9.2.3 Others
9.3 Market Segment by Application
9.3.1 World Recombinant Glycoproteins Production by Application (2021-2032)
9.3.2 World Recombinant Glycoproteins Production Value by Application (2021-2032)
9.3.3 World Recombinant Glycoproteins Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Roche
10.1.1 Roche Details
10.1.2 Roche Major Business
10.1.3 Roche Recombinant Glycoproteins Product and Services
10.1.4 Roche Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Roche Recent Developments/Updates
10.1.6 Roche Competitive Strengths & Weaknesses
10.2 Pfizer
10.2.1 Pfizer Details
10.2.2 Pfizer Major Business
10.2.3 Pfizer Recombinant Glycoproteins Product and Services
10.2.4 Pfizer Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Pfizer Recent Developments/Updates
10.2.6 Pfizer Competitive Strengths & Weaknesses
10.3 Novartis
10.3.1 Novartis Details
10.3.2 Novartis Major Business
10.3.3 Novartis Recombinant Glycoproteins Product and Services
10.3.4 Novartis Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Novartis Recent Developments/Updates
10.3.6 Novartis Competitive Strengths & Weaknesses
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Details
10.4.2 Johnson & Johnson Major Business
10.4.3 Johnson & Johnson Recombinant Glycoproteins Product and Services
10.4.4 Johnson & Johnson Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Johnson & Johnson Recent Developments/Updates
10.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
10.5 Merck
10.5.1 Merck Details
10.5.2 Merck Major Business
10.5.3 Merck Recombinant Glycoproteins Product and Services
10.5.4 Merck Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Merck Recent Developments/Updates
10.5.6 Merck Competitive Strengths & Weaknesses
10.6 AstraZeneca
10.6.1 AstraZeneca Details
10.6.2 AstraZeneca Major Business
10.6.3 AstraZeneca Recombinant Glycoproteins Product and Services
10.6.4 AstraZeneca Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 AstraZeneca Recent Developments/Updates
10.6.6 AstraZeneca Competitive Strengths & Weaknesses
10.7 Sanofi
10.7.1 Sanofi Details
10.7.2 Sanofi Major Business
10.7.3 Sanofi Recombinant Glycoproteins Product and Services
10.7.4 Sanofi Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Sanofi Recent Developments/Updates
10.7.6 Sanofi Competitive Strengths & Weaknesses
10.8 Bristol Myers Squibb
10.8.1 Bristol Myers Squibb Details
10.8.2 Bristol Myers Squibb Major Business
10.8.3 Bristol Myers Squibb Recombinant Glycoproteins Product and Services
10.8.4 Bristol Myers Squibb Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Bristol Myers Squibb Recent Developments/Updates
10.8.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
10.9 Amgen
10.9.1 Amgen Details
10.9.2 Amgen Major Business
10.9.3 Amgen Recombinant Glycoproteins Product and Services
10.9.4 Amgen Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Amgen Recent Developments/Updates
10.9.6 Amgen Competitive Strengths & Weaknesses
10.10 Regeneron
10.10.1 Regeneron Details
10.10.2 Regeneron Major Business
10.10.3 Regeneron Recombinant Glycoproteins Product and Services
10.10.4 Regeneron Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Regeneron Recent Developments/Updates
10.10.6 Regeneron Competitive Strengths & Weaknesses
10.11 Sandoz
10.11.1 Sandoz Details
10.11.2 Sandoz Major Business
10.11.3 Sandoz Recombinant Glycoproteins Product and Services
10.11.4 Sandoz Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 Sandoz Recent Developments/Updates
10.11.6 Sandoz Competitive Strengths & Weaknesses
10.12 Teva
10.12.1 Teva Details
10.12.2 Teva Major Business
10.12.3 Teva Recombinant Glycoproteins Product and Services
10.12.4 Teva Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.12.5 Teva Recent Developments/Updates
10.12.6 Teva Competitive Strengths & Weaknesses
10.13 Fresenius Kabi
10.13.1 Fresenius Kabi Details
10.13.2 Fresenius Kabi Major Business
10.13.3 Fresenius Kabi Recombinant Glycoproteins Product and Services
10.13.4 Fresenius Kabi Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.13.5 Fresenius Kabi Recent Developments/Updates
10.13.6 Fresenius Kabi Competitive Strengths & Weaknesses
10.14 STADA
10.14.1 STADA Details
10.14.2 STADA Major Business
10.14.3 STADA Recombinant Glycoproteins Product and Services
10.14.4 STADA Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.14.5 STADA Recent Developments/Updates
10.14.6 STADA Competitive Strengths & Weaknesses
10.15 Biogen
10.15.1 Biogen Details
10.15.2 Biogen Major Business
10.15.3 Biogen Recombinant Glycoproteins Product and Services
10.15.4 Biogen Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.15.5 Biogen Recent Developments/Updates
10.15.6 Biogen Competitive Strengths & Weaknesses
10.16 Celltrion
10.16.1 Celltrion Details
10.16.2 Celltrion Major Business
10.16.3 Celltrion Recombinant Glycoproteins Product and Services
10.16.4 Celltrion Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.16.5 Celltrion Recent Developments/Updates
10.16.6 Celltrion Competitive Strengths & Weaknesses
10.17 Samsung Bioepis
10.17.1 Samsung Bioepis Details
10.17.2 Samsung Bioepis Major Business
10.17.3 Samsung Bioepis Recombinant Glycoproteins Product and Services
10.17.4 Samsung Bioepis Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.17.5 Samsung Bioepis Recent Developments/Updates
10.17.6 Samsung Bioepis Competitive Strengths & Weaknesses
10.18 Samsung Biologics
10.18.1 Samsung Biologics Details
10.18.2 Samsung Biologics Major Business
10.18.3 Samsung Biologics Recombinant Glycoproteins Product and Services
10.18.4 Samsung Biologics Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.18.5 Samsung Biologics Recent Developments/Updates
10.18.6 Samsung Biologics Competitive Strengths & Weaknesses
10.19 Biocon
10.19.1 Biocon Details
10.19.2 Biocon Major Business
10.19.3 Biocon Recombinant Glycoproteins Product and Services
10.19.4 Biocon Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.19.5 Biocon Recent Developments/Updates
10.19.6 Biocon Competitive Strengths & Weaknesses
10.20 Intas
10.20.1 Intas Details
10.20.2 Intas Major Business
10.20.3 Intas Recombinant Glycoproteins Product and Services
10.20.4 Intas Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.20.5 Intas Recent Developments/Updates
10.20.6 Intas Competitive Strengths & Weaknesses
10.21 Dr. Reddy?s
10.21.1 Dr. Reddy?s Details
10.21.2 Dr. Reddy?s Major Business
10.21.3 Dr. Reddy?s Recombinant Glycoproteins Product and Services
10.21.4 Dr. Reddy?s Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.21.5 Dr. Reddy?s Recent Developments/Updates
10.21.6 Dr. Reddy?s Competitive Strengths & Weaknesses
10.22 Apotex
10.22.1 Apotex Details
10.22.2 Apotex Major Business
10.22.3 Apotex Recombinant Glycoproteins Product and Services
10.22.4 Apotex Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.22.5 Apotex Recent Developments/Updates
10.22.6 Apotex Competitive Strengths & Weaknesses
10.23 Alvotech
10.23.1 Alvotech Details
10.23.2 Alvotech Major Business
10.23.3 Alvotech Recombinant Glycoproteins Product and Services
10.23.4 Alvotech Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.23.5 Alvotech Recent Developments/Updates
10.23.6 Alvotech Competitive Strengths & Weaknesses
10.24 Coherus
10.24.1 Coherus Details
10.24.2 Coherus Major Business
10.24.3 Coherus Recombinant Glycoproteins Product and Services
10.24.4 Coherus Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.24.5 Coherus Recent Developments/Updates
10.24.6 Coherus Competitive Strengths & Weaknesses
10.25 Boehringer Ingelheim
10.25.1 Boehringer Ingelheim Details
10.25.2 Boehringer Ingelheim Major Business
10.25.3 Boehringer Ingelheim Recombinant Glycoproteins Product and Services
10.25.4 Boehringer Ingelheim Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.25.5 Boehringer Ingelheim Recent Developments/Updates
10.25.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
10.26 Lonza
10.26.1 Lonza Details
10.26.2 Lonza Major Business
10.26.3 Lonza Recombinant Glycoproteins Product and Services
10.26.4 Lonza Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.26.5 Lonza Recent Developments/Updates
10.26.6 Lonza Competitive Strengths & Weaknesses
10.27 FUJIFILM Diosynth Biotechnologies
10.27.1 FUJIFILM Diosynth Biotechnologies Details
10.27.2 FUJIFILM Diosynth Biotechnologies Major Business
10.27.3 FUJIFILM Diosynth Biotechnologies Recombinant Glycoproteins Product and Services
10.27.4 FUJIFILM Diosynth Biotechnologies Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.27.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
10.27.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
10.28 WuXi Biologics
10.28.1 WuXi Biologics Details
10.28.2 WuXi Biologics Major Business
10.28.3 WuXi Biologics Recombinant Glycoproteins Product and Services
10.28.4 WuXi Biologics Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.28.5 WuXi Biologics Recent Developments/Updates
10.28.6 WuXi Biologics Competitive Strengths & Weaknesses
10.29 Bio-Thera Solutions
10.29.1 Bio-Thera Solutions Details
10.29.2 Bio-Thera Solutions Major Business
10.29.3 Bio-Thera Solutions Recombinant Glycoproteins Product and Services
10.29.4 Bio-Thera Solutions Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.29.5 Bio-Thera Solutions Recent Developments/Updates
10.29.6 Bio-Thera Solutions Competitive Strengths & Weaknesses
10.30 Henlius
10.30.1 Henlius Details
10.30.2 Henlius Major Business
10.30.3 Henlius Recombinant Glycoproteins Product and Services
10.30.4 Henlius Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.30.5 Henlius Recent Developments/Updates
10.30.6 Henlius Competitive Strengths & Weaknesses
10.31 Innovent Biologics
10.31.1 Innovent Biologics Details
10.31.2 Innovent Biologics Major Business
10.31.3 Innovent Biologics Recombinant Glycoproteins Product and Services
10.31.4 Innovent Biologics Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.31.5 Innovent Biologics Recent Developments/Updates
10.31.6 Innovent Biologics Competitive Strengths & Weaknesses
10.32 Hengrui Pharmaceutical
10.32.1 Hengrui Pharmaceutical Details
10.32.2 Hengrui Pharmaceutical Major Business
10.32.3 Hengrui Pharmaceutical Recombinant Glycoproteins Product and Services
10.32.4 Hengrui Pharmaceutical Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.32.5 Hengrui Pharmaceutical Recent Developments/Updates
10.32.6 Hengrui Pharmaceutical Competitive Strengths & Weaknesses
10.33 Junshi Biosciences
10.33.1 Junshi Biosciences Details
10.33.2 Junshi Biosciences Major Business
10.33.3 Junshi Biosciences Recombinant Glycoproteins Product and Services
10.33.4 Junshi Biosciences Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.33.5 Junshi Biosciences Recent Developments/Updates
10.33.6 Junshi Biosciences Competitive Strengths & Weaknesses
10.34 Sino Biological
10.34.1 Sino Biological Details
10.34.2 Sino Biological Major Business
10.34.3 Sino Biological Recombinant Glycoproteins Product and Services
10.34.4 Sino Biological Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.34.5 Sino Biological Recent Developments/Updates
10.34.6 Sino Biological Competitive Strengths & Weaknesses
10.35 ACROBiosystems
10.35.1 ACROBiosystems Details
10.35.2 ACROBiosystems Major Business
10.35.3 ACROBiosystems Recombinant Glycoproteins Product and Services
10.35.4 ACROBiosystems Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.35.5 ACROBiosystems Recent Developments/Updates
10.35.6 ACROBiosystems Competitive Strengths & Weaknesses
10.36 GenScript
10.36.1 GenScript Details
10.36.2 GenScript Major Business
10.36.3 GenScript Recombinant Glycoproteins Product and Services
10.36.4 GenScript Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.36.5 GenScript Recent Developments/Updates
10.36.6 GenScript Competitive Strengths & Weaknesses
10.37 Bio-Techne
10.37.1 Bio-Techne Details
10.37.2 Bio-Techne Major Business
10.37.3 Bio-Techne Recombinant Glycoproteins Product and Services
10.37.4 Bio-Techne Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.37.5 Bio-Techne Recent Developments/Updates
10.37.6 Bio-Techne Competitive Strengths & Weaknesses
10.38 Takeda
10.38.1 Takeda Details
10.38.2 Takeda Major Business
10.38.3 Takeda Recombinant Glycoproteins Product and Services
10.38.4 Takeda Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.38.5 Takeda Recent Developments/Updates
10.38.6 Takeda Competitive Strengths & Weaknesses
10.39 Kyowa Kirin
10.39.1 Kyowa Kirin Details
10.39.2 Kyowa Kirin Major Business
10.39.3 Kyowa Kirin Recombinant Glycoproteins Product and Services
10.39.4 Kyowa Kirin Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.39.5 Kyowa Kirin Recent Developments/Updates
10.39.6 Kyowa Kirin Competitive Strengths & Weaknesses
10.40 Daiichi Sankyo
10.40.1 Daiichi Sankyo Details
10.40.2 Daiichi Sankyo Major Business
10.40.3 Daiichi Sankyo Recombinant Glycoproteins Product and Services
10.40.4 Daiichi Sankyo Recombinant Glycoproteins Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.40.5 Daiichi Sankyo Recent Developments/Updates
10.40.6 Daiichi Sankyo Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Recombinant Glycoproteins Industry Chain
11.2 Recombinant Glycoproteins Upstream Analysis
11.2.1 Recombinant Glycoproteins Core Raw Materials
11.2.2 Main Manufacturers of Recombinant Glycoproteins Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Recombinant Glycoproteins Production Mode
11.6 Recombinant Glycoproteins Procurement Model
11.7 Recombinant Glycoproteins Industry Sales Model and Sales Channels
11.7.1 Recombinant Glycoproteins Sales Model
11.7.2 Recombinant Glycoproteins Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Recombinant Glycoproteins Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Recombinant Glycoproteins Production Value by Region (2021-2026) & (USD Million)
Table 3. World Recombinant Glycoproteins Production Value by Region (2027-2032) & (USD Million)
Table 4. World Recombinant Glycoproteins Production Value Market Share by Region (2021-2026)
Table 5. World Recombinant Glycoproteins Production Value Market Share by Region (2027-2032)
Table 6. World Recombinant Glycoproteins Production by Region (2021-2026) & (MT)
Table 7. World Recombinant Glycoproteins Production by Region (2027-2032) & (MT)
Table 8. World Recombinant Glycoproteins Production Market Share by Region (2021-2026)
Table 9. World Recombinant Glycoproteins Production Market Share by Region (2027-2032)
Table 10. World Recombinant Glycoproteins Average Price by Region (2021-2026) & (USD/MT)
Table 11. World Recombinant Glycoproteins Average Price by Region (2027-2032) & (USD/MT)
Table 12. Recombinant Glycoproteins Major Market Trends
Table 13. World Recombinant Glycoproteins Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (MT)
Table 14. World Recombinant Glycoproteins Consumption by Region (2021-2026) & (MT)
Table 15. World Recombinant Glycoproteins Consumption Forecast by Region (2027-2032) & (MT)
Table 16. World Recombinant Glycoproteins Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Glycoproteins Producers in 2025
Table 18. World Recombinant Glycoproteins Production by Manufacturer (2021-2026) & (MT)
Table 19. Production Market Share of Key Recombinant Glycoproteins Producers in 2025
Table 20. World Recombinant Glycoproteins Average Price by Manufacturer (2021-2026) & (USD/MT)
Table 21. Global Recombinant Glycoproteins Company Evaluation Quadrant
Table 22. World Recombinant Glycoproteins Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Recombinant Glycoproteins Production Site of Key Manufacturer
Table 24. Recombinant Glycoproteins Market: Company Product Type Footprint
Table 25. Recombinant Glycoproteins Market: Company Product Application Footprint
Table 26. Recombinant Glycoproteins Competitive Factors
Table 27. Recombinant Glycoproteins New Entrant and Capacity Expansion Plans
Table 28. Recombinant Glycoproteins Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Glycoproteins Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Recombinant Glycoproteins Production Comparison, (2021 & 2025 & 2032) & (MT)
Table 31. United States VS China Recombinant Glycoproteins Consumption Comparison, (2021 & 2025 & 2032) & (MT)
Table 32. United States Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Glycoproteins Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Glycoproteins Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Recombinant Glycoproteins Production (2021-2026) & (MT)
Table 36. United States Based Manufacturers Recombinant Glycoproteins Production Market Share (2021-2026)
Table 37. China Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Glycoproteins Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Recombinant Glycoproteins Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Recombinant Glycoproteins Production, (2021-2026) & (MT)
Table 41. China Based Manufacturers Recombinant Glycoproteins Production Market Share (2021-2026)
Table 42. Rest of World Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Recombinant Glycoproteins Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Glycoproteins Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Recombinant Glycoproteins Production, (2021-2026) & (MT)
Table 46. Rest of World Based Manufacturers Recombinant Glycoproteins Production Market Share (2021-2026)
Table 47. World Recombinant Glycoproteins Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Recombinant Glycoproteins Production by Type (2021-2026) & (MT)
Table 49. World Recombinant Glycoproteins Production by Type (2027-2032) & (MT)
Table 50. World Recombinant Glycoproteins Production Value by Type (2021-2026) & (USD Million)
Table 51. World Recombinant Glycoproteins Production Value by Type (2027-2032) & (USD Million)
Table 52. World Recombinant Glycoproteins Average Price by Type (2021-2026) & (USD/MT)
Table 53. World Recombinant Glycoproteins Average Price by Type (2027-2032) & (USD/MT)
Table 54. World Recombinant Glycoproteins Production Value by Expression System, (USD Million), 2021 & 2025 & 2032
Table 55. World Recombinant Glycoproteins Production by Expression System (2021-2026) & (MT)
Table 56. World Recombinant Glycoproteins Production by Expression System (2027-2032) & (MT)
Table 57. World Recombinant Glycoproteins Production Value by Expression System (2021-2026) & (USD Million)
Table 58. World Recombinant Glycoproteins Production Value by Expression System (2027-2032) & (USD Million)
Table 59. World Recombinant Glycoproteins Average Price by Expression System (2021-2026) & (USD/MT)
Table 60. World Recombinant Glycoproteins Average Price by Expression System (2027-2032) & (USD/MT)
Table 61. World Recombinant Glycoproteins Production Value by Product Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Recombinant Glycoproteins Production by Product Form (2021-2026) & (MT)
Table 63. World Recombinant Glycoproteins Production by Product Form (2027-2032) & (MT)
Table 64. World Recombinant Glycoproteins Production Value by Product Form (2021-2026) & (USD Million)
Table 65. World Recombinant Glycoproteins Production Value by Product Form (2027-2032) & (USD Million)
Table 66. World Recombinant Glycoproteins Average Price by Product Form (2021-2026) & (USD/MT)
Table 67. World Recombinant Glycoproteins Average Price by Product Form (2027-2032) & (USD/MT)
Table 68. World Recombinant Glycoproteins Production Value by Glycosylation Type, (USD Million), 2021 & 2025 & 2032
Table 69. World Recombinant Glycoproteins Production by Glycosylation Type (2021-2026) & (MT)
Table 70. World Recombinant Glycoproteins Production by Glycosylation Type (2027-2032) & (MT)
Table 71. World Recombinant Glycoproteins Production Value by Glycosylation Type (2021-2026) & (USD Million)
Table 72. World Recombinant Glycoproteins Production Value by Glycosylation Type (2027-2032) & (USD Million)
Table 73. World Recombinant Glycoproteins Average Price by Glycosylation Type (2021-2026) & (USD/MT)
Table 74. World Recombinant Glycoproteins Average Price by Glycosylation Type (2027-2032) & (USD/MT)
Table 75. World Recombinant Glycoproteins Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Recombinant Glycoproteins Production by Application (2021-2026) & (MT)
Table 77. World Recombinant Glycoproteins Production by Application (2027-2032) & (MT)
Table 78. World Recombinant Glycoproteins Production Value by Application (2021-2026) & (USD Million)
Table 79. World Recombinant Glycoproteins Production Value by Application (2027-2032) & (USD Million)
Table 80. World Recombinant Glycoproteins Average Price by Application (2021-2026) & (USD/MT)
Table 81. World Recombinant Glycoproteins Average Price by Application (2027-2032) & (USD/MT)
Table 82. Roche Basic Information, Manufacturing Base and Competitors
Table 83. Roche Major Business
Table 84. Roche Recombinant Glycoproteins Product and Services
Table 85. Roche Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Roche Recent Developments/Updates
Table 87. Roche Competitive Strengths & Weaknesses
Table 88. Pfizer Basic Information, Manufacturing Base and Competitors
Table 89. Pfizer Major Business
Table 90. Pfizer Recombinant Glycoproteins Product and Services
Table 91. Pfizer Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Pfizer Recent Developments/Updates
Table 93. Pfizer Competitive Strengths & Weaknesses
Table 94. Novartis Basic Information, Manufacturing Base and Competitors
Table 95. Novartis Major Business
Table 96. Novartis Recombinant Glycoproteins Product and Services
Table 97. Novartis Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Novartis Recent Developments/Updates
Table 99. Novartis Competitive Strengths & Weaknesses
Table 100. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 101. Johnson & Johnson Major Business
Table 102. Johnson & Johnson Recombinant Glycoproteins Product and Services
Table 103. Johnson & Johnson Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Johnson & Johnson Competitive Strengths & Weaknesses
Table 106. Merck Basic Information, Manufacturing Base and Competitors
Table 107. Merck Major Business
Table 108. Merck Recombinant Glycoproteins Product and Services
Table 109. Merck Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Merck Recent Developments/Updates
Table 111. Merck Competitive Strengths & Weaknesses
Table 112. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 113. AstraZeneca Major Business
Table 114. AstraZeneca Recombinant Glycoproteins Product and Services
Table 115. AstraZeneca Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. AstraZeneca Recent Developments/Updates
Table 117. AstraZeneca Competitive Strengths & Weaknesses
Table 118. Sanofi Basic Information, Manufacturing Base and Competitors
Table 119. Sanofi Major Business
Table 120. Sanofi Recombinant Glycoproteins Product and Services
Table 121. Sanofi Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Sanofi Recent Developments/Updates
Table 123. Sanofi Competitive Strengths & Weaknesses
Table 124. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 125. Bristol Myers Squibb Major Business
Table 126. Bristol Myers Squibb Recombinant Glycoproteins Product and Services
Table 127. Bristol Myers Squibb Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Bristol Myers Squibb Recent Developments/Updates
Table 129. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 130. Amgen Basic Information, Manufacturing Base and Competitors
Table 131. Amgen Major Business
Table 132. Amgen Recombinant Glycoproteins Product and Services
Table 133. Amgen Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Amgen Recent Developments/Updates
Table 135. Amgen Competitive Strengths & Weaknesses
Table 136. Regeneron Basic Information, Manufacturing Base and Competitors
Table 137. Regeneron Major Business
Table 138. Regeneron Recombinant Glycoproteins Product and Services
Table 139. Regeneron Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Regeneron Recent Developments/Updates
Table 141. Regeneron Competitive Strengths & Weaknesses
Table 142. Sandoz Basic Information, Manufacturing Base and Competitors
Table 143. Sandoz Major Business
Table 144. Sandoz Recombinant Glycoproteins Product and Services
Table 145. Sandoz Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Sandoz Recent Developments/Updates
Table 147. Sandoz Competitive Strengths & Weaknesses
Table 148. Teva Basic Information, Manufacturing Base and Competitors
Table 149. Teva Major Business
Table 150. Teva Recombinant Glycoproteins Product and Services
Table 151. Teva Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 152. Teva Recent Developments/Updates
Table 153. Teva Competitive Strengths & Weaknesses
Table 154. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 155. Fresenius Kabi Major Business
Table 156. Fresenius Kabi Recombinant Glycoproteins Product and Services
Table 157. Fresenius Kabi Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 158. Fresenius Kabi Recent Developments/Updates
Table 159. Fresenius Kabi Competitive Strengths & Weaknesses
Table 160. STADA Basic Information, Manufacturing Base and Competitors
Table 161. STADA Major Business
Table 162. STADA Recombinant Glycoproteins Product and Services
Table 163. STADA Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 164. STADA Recent Developments/Updates
Table 165. STADA Competitive Strengths & Weaknesses
Table 166. Biogen Basic Information, Manufacturing Base and Competitors
Table 167. Biogen Major Business
Table 168. Biogen Recombinant Glycoproteins Product and Services
Table 169. Biogen Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Biogen Recent Developments/Updates
Table 171. Biogen Competitive Strengths & Weaknesses
Table 172. Celltrion Basic Information, Manufacturing Base and Competitors
Table 173. Celltrion Major Business
Table 174. Celltrion Recombinant Glycoproteins Product and Services
Table 175. Celltrion Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 176. Celltrion Recent Developments/Updates
Table 177. Celltrion Competitive Strengths & Weaknesses
Table 178. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 179. Samsung Bioepis Major Business
Table 180. Samsung Bioepis Recombinant Glycoproteins Product and Services
Table 181. Samsung Bioepis Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 182. Samsung Bioepis Recent Developments/Updates
Table 183. Samsung Bioepis Competitive Strengths & Weaknesses
Table 184. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 185. Samsung Biologics Major Business
Table 186. Samsung Biologics Recombinant Glycoproteins Product and Services
Table 187. Samsung Biologics Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 188. Samsung Biologics Recent Developments/Updates
Table 189. Samsung Biologics Competitive Strengths & Weaknesses
Table 190. Biocon Basic Information, Manufacturing Base and Competitors
Table 191. Biocon Major Business
Table 192. Biocon Recombinant Glycoproteins Product and Services
Table 193. Biocon Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 194. Biocon Recent Developments/Updates
Table 195. Biocon Competitive Strengths & Weaknesses
Table 196. Intas Basic Information, Manufacturing Base and Competitors
Table 197. Intas Major Business
Table 198. Intas Recombinant Glycoproteins Product and Services
Table 199. Intas Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Intas Recent Developments/Updates
Table 201. Intas Competitive Strengths & Weaknesses
Table 202. Dr. Reddy?s Basic Information, Manufacturing Base and Competitors
Table 203. Dr. Reddy?s Major Business
Table 204. Dr. Reddy?s Recombinant Glycoproteins Product and Services
Table 205. Dr. Reddy?s Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 206. Dr. Reddy?s Recent Developments/Updates
Table 207. Dr. Reddy?s Competitive Strengths & Weaknesses
Table 208. Apotex Basic Information, Manufacturing Base and Competitors
Table 209. Apotex Major Business
Table 210. Apotex Recombinant Glycoproteins Product and Services
Table 211. Apotex Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 212. Apotex Recent Developments/Updates
Table 213. Apotex Competitive Strengths & Weaknesses
Table 214. Alvotech Basic Information, Manufacturing Base and Competitors
Table 215. Alvotech Major Business
Table 216. Alvotech Recombinant Glycoproteins Product and Services
Table 217. Alvotech Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 218. Alvotech Recent Developments/Updates
Table 219. Alvotech Competitive Strengths & Weaknesses
Table 220. Coherus Basic Information, Manufacturing Base and Competitors
Table 221. Coherus Major Business
Table 222. Coherus Recombinant Glycoproteins Product and Services
Table 223. Coherus Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 224. Coherus Recent Developments/Updates
Table 225. Coherus Competitive Strengths & Weaknesses
Table 226. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 227. Boehringer Ingelheim Major Business
Table 228. Boehringer Ingelheim Recombinant Glycoproteins Product and Services
Table 229. Boehringer Ingelheim Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 230. Boehringer Ingelheim Recent Developments/Updates
Table 231. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 232. Lonza Basic Information, Manufacturing Base and Competitors
Table 233. Lonza Major Business
Table 234. Lonza Recombinant Glycoproteins Product and Services
Table 235. Lonza Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 236. Lonza Recent Developments/Updates
Table 237. Lonza Competitive Strengths & Weaknesses
Table 238. FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 239. FUJIFILM Diosynth Biotechnologies Major Business
Table 240. FUJIFILM Diosynth Biotechnologies Recombinant Glycoproteins Product and Services
Table 241. FUJIFILM Diosynth Biotechnologies Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 242. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 243. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 244. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 245. WuXi Biologics Major Business
Table 246. WuXi Biologics Recombinant Glycoproteins Product and Services
Table 247. WuXi Biologics Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 248. WuXi Biologics Recent Developments/Updates
Table 249. WuXi Biologics Competitive Strengths & Weaknesses
Table 250. Bio-Thera Solutions Basic Information, Manufacturing Base and Competitors
Table 251. Bio-Thera Solutions Major Business
Table 252. Bio-Thera Solutions Recombinant Glycoproteins Product and Services
Table 253. Bio-Thera Solutions Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 254. Bio-Thera Solutions Recent Developments/Updates
Table 255. Bio-Thera Solutions Competitive Strengths & Weaknesses
Table 256. Henlius Basic Information, Manufacturing Base and Competitors
Table 257. Henlius Major Business
Table 258. Henlius Recombinant Glycoproteins Product and Services
Table 259. Henlius Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 260. Henlius Recent Developments/Updates
Table 261. Henlius Competitive Strengths & Weaknesses
Table 262. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 263. Innovent Biologics Major Business
Table 264. Innovent Biologics Recombinant Glycoproteins Product and Services
Table 265. Innovent Biologics Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 266. Innovent Biologics Recent Developments/Updates
Table 267. Innovent Biologics Competitive Strengths & Weaknesses
Table 268. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 269. Hengrui Pharmaceutical Major Business
Table 270. Hengrui Pharmaceutical Recombinant Glycoproteins Product and Services
Table 271. Hengrui Pharmaceutical Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 272. Hengrui Pharmaceutical Recent Developments/Updates
Table 273. Hengrui Pharmaceutical Competitive Strengths & Weaknesses
Table 274. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 275. Junshi Biosciences Major Business
Table 276. Junshi Biosciences Recombinant Glycoproteins Product and Services
Table 277. Junshi Biosciences Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 278. Junshi Biosciences Recent Developments/Updates
Table 279. Junshi Biosciences Competitive Strengths & Weaknesses
Table 280. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 281. Sino Biological Major Business
Table 282. Sino Biological Recombinant Glycoproteins Product and Services
Table 283. Sino Biological Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 284. Sino Biological Recent Developments/Updates
Table 285. Sino Biological Competitive Strengths & Weaknesses
Table 286. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 287. ACROBiosystems Major Business
Table 288. ACROBiosystems Recombinant Glycoproteins Product and Services
Table 289. ACROBiosystems Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 290. ACROBiosystems Recent Developments/Updates
Table 291. ACROBiosystems Competitive Strengths & Weaknesses
Table 292. GenScript Basic Information, Manufacturing Base and Competitors
Table 293. GenScript Major Business
Table 294. GenScript Recombinant Glycoproteins Product and Services
Table 295. GenScript Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 296. GenScript Recent Developments/Updates
Table 297. GenScript Competitive Strengths & Weaknesses
Table 298. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 299. Bio-Techne Major Business
Table 300. Bio-Techne Recombinant Glycoproteins Product and Services
Table 301. Bio-Techne Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 302. Bio-Techne Recent Developments/Updates
Table 303. Bio-Techne Competitive Strengths & Weaknesses
Table 304. Takeda Basic Information, Manufacturing Base and Competitors
Table 305. Takeda Major Business
Table 306. Takeda Recombinant Glycoproteins Product and Services
Table 307. Takeda Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 308. Takeda Recent Developments/Updates
Table 309. Takeda Competitive Strengths & Weaknesses
Table 310. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 311. Kyowa Kirin Major Business
Table 312. Kyowa Kirin Recombinant Glycoproteins Product and Services
Table 313. Kyowa Kirin Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 314. Kyowa Kirin Recent Developments/Updates
Table 315. Kyowa Kirin Competitive Strengths & Weaknesses
Table 316. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 317. Daiichi Sankyo Major Business
Table 318. Daiichi Sankyo Recombinant Glycoproteins Product and Services
Table 319. Daiichi Sankyo Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 320. Daiichi Sankyo Recent Developments/Updates
Table 321. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 322. Global Key Players of Recombinant Glycoproteins Upstream (Raw Materials)
Table 323. Global Recombinant Glycoproteins Typical Customers
Table 324. Recombinant Glycoproteins Typical Distributors
Table 1. World Recombinant Glycoproteins Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Recombinant Glycoproteins Production Value by Region (2021-2026) & (USD Million)
Table 3. World Recombinant Glycoproteins Production Value by Region (2027-2032) & (USD Million)
Table 4. World Recombinant Glycoproteins Production Value Market Share by Region (2021-2026)
Table 5. World Recombinant Glycoproteins Production Value Market Share by Region (2027-2032)
Table 6. World Recombinant Glycoproteins Production by Region (2021-2026) & (MT)
Table 7. World Recombinant Glycoproteins Production by Region (2027-2032) & (MT)
Table 8. World Recombinant Glycoproteins Production Market Share by Region (2021-2026)
Table 9. World Recombinant Glycoproteins Production Market Share by Region (2027-2032)
Table 10. World Recombinant Glycoproteins Average Price by Region (2021-2026) & (USD/MT)
Table 11. World Recombinant Glycoproteins Average Price by Region (2027-2032) & (USD/MT)
Table 12. Recombinant Glycoproteins Major Market Trends
Table 13. World Recombinant Glycoproteins Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (MT)
Table 14. World Recombinant Glycoproteins Consumption by Region (2021-2026) & (MT)
Table 15. World Recombinant Glycoproteins Consumption Forecast by Region (2027-2032) & (MT)
Table 16. World Recombinant Glycoproteins Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Glycoproteins Producers in 2025
Table 18. World Recombinant Glycoproteins Production by Manufacturer (2021-2026) & (MT)
Table 19. Production Market Share of Key Recombinant Glycoproteins Producers in 2025
Table 20. World Recombinant Glycoproteins Average Price by Manufacturer (2021-2026) & (USD/MT)
Table 21. Global Recombinant Glycoproteins Company Evaluation Quadrant
Table 22. World Recombinant Glycoproteins Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Recombinant Glycoproteins Production Site of Key Manufacturer
Table 24. Recombinant Glycoproteins Market: Company Product Type Footprint
Table 25. Recombinant Glycoproteins Market: Company Product Application Footprint
Table 26. Recombinant Glycoproteins Competitive Factors
Table 27. Recombinant Glycoproteins New Entrant and Capacity Expansion Plans
Table 28. Recombinant Glycoproteins Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Glycoproteins Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Recombinant Glycoproteins Production Comparison, (2021 & 2025 & 2032) & (MT)
Table 31. United States VS China Recombinant Glycoproteins Consumption Comparison, (2021 & 2025 & 2032) & (MT)
Table 32. United States Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Glycoproteins Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Glycoproteins Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Recombinant Glycoproteins Production (2021-2026) & (MT)
Table 36. United States Based Manufacturers Recombinant Glycoproteins Production Market Share (2021-2026)
Table 37. China Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Glycoproteins Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Recombinant Glycoproteins Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Recombinant Glycoproteins Production, (2021-2026) & (MT)
Table 41. China Based Manufacturers Recombinant Glycoproteins Production Market Share (2021-2026)
Table 42. Rest of World Based Recombinant Glycoproteins Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Recombinant Glycoproteins Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Glycoproteins Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Recombinant Glycoproteins Production, (2021-2026) & (MT)
Table 46. Rest of World Based Manufacturers Recombinant Glycoproteins Production Market Share (2021-2026)
Table 47. World Recombinant Glycoproteins Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Recombinant Glycoproteins Production by Type (2021-2026) & (MT)
Table 49. World Recombinant Glycoproteins Production by Type (2027-2032) & (MT)
Table 50. World Recombinant Glycoproteins Production Value by Type (2021-2026) & (USD Million)
Table 51. World Recombinant Glycoproteins Production Value by Type (2027-2032) & (USD Million)
Table 52. World Recombinant Glycoproteins Average Price by Type (2021-2026) & (USD/MT)
Table 53. World Recombinant Glycoproteins Average Price by Type (2027-2032) & (USD/MT)
Table 54. World Recombinant Glycoproteins Production Value by Expression System, (USD Million), 2021 & 2025 & 2032
Table 55. World Recombinant Glycoproteins Production by Expression System (2021-2026) & (MT)
Table 56. World Recombinant Glycoproteins Production by Expression System (2027-2032) & (MT)
Table 57. World Recombinant Glycoproteins Production Value by Expression System (2021-2026) & (USD Million)
Table 58. World Recombinant Glycoproteins Production Value by Expression System (2027-2032) & (USD Million)
Table 59. World Recombinant Glycoproteins Average Price by Expression System (2021-2026) & (USD/MT)
Table 60. World Recombinant Glycoproteins Average Price by Expression System (2027-2032) & (USD/MT)
Table 61. World Recombinant Glycoproteins Production Value by Product Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Recombinant Glycoproteins Production by Product Form (2021-2026) & (MT)
Table 63. World Recombinant Glycoproteins Production by Product Form (2027-2032) & (MT)
Table 64. World Recombinant Glycoproteins Production Value by Product Form (2021-2026) & (USD Million)
Table 65. World Recombinant Glycoproteins Production Value by Product Form (2027-2032) & (USD Million)
Table 66. World Recombinant Glycoproteins Average Price by Product Form (2021-2026) & (USD/MT)
Table 67. World Recombinant Glycoproteins Average Price by Product Form (2027-2032) & (USD/MT)
Table 68. World Recombinant Glycoproteins Production Value by Glycosylation Type, (USD Million), 2021 & 2025 & 2032
Table 69. World Recombinant Glycoproteins Production by Glycosylation Type (2021-2026) & (MT)
Table 70. World Recombinant Glycoproteins Production by Glycosylation Type (2027-2032) & (MT)
Table 71. World Recombinant Glycoproteins Production Value by Glycosylation Type (2021-2026) & (USD Million)
Table 72. World Recombinant Glycoproteins Production Value by Glycosylation Type (2027-2032) & (USD Million)
Table 73. World Recombinant Glycoproteins Average Price by Glycosylation Type (2021-2026) & (USD/MT)
Table 74. World Recombinant Glycoproteins Average Price by Glycosylation Type (2027-2032) & (USD/MT)
Table 75. World Recombinant Glycoproteins Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Recombinant Glycoproteins Production by Application (2021-2026) & (MT)
Table 77. World Recombinant Glycoproteins Production by Application (2027-2032) & (MT)
Table 78. World Recombinant Glycoproteins Production Value by Application (2021-2026) & (USD Million)
Table 79. World Recombinant Glycoproteins Production Value by Application (2027-2032) & (USD Million)
Table 80. World Recombinant Glycoproteins Average Price by Application (2021-2026) & (USD/MT)
Table 81. World Recombinant Glycoproteins Average Price by Application (2027-2032) & (USD/MT)
Table 82. Roche Basic Information, Manufacturing Base and Competitors
Table 83. Roche Major Business
Table 84. Roche Recombinant Glycoproteins Product and Services
Table 85. Roche Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Roche Recent Developments/Updates
Table 87. Roche Competitive Strengths & Weaknesses
Table 88. Pfizer Basic Information, Manufacturing Base and Competitors
Table 89. Pfizer Major Business
Table 90. Pfizer Recombinant Glycoproteins Product and Services
Table 91. Pfizer Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Pfizer Recent Developments/Updates
Table 93. Pfizer Competitive Strengths & Weaknesses
Table 94. Novartis Basic Information, Manufacturing Base and Competitors
Table 95. Novartis Major Business
Table 96. Novartis Recombinant Glycoproteins Product and Services
Table 97. Novartis Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Novartis Recent Developments/Updates
Table 99. Novartis Competitive Strengths & Weaknesses
Table 100. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 101. Johnson & Johnson Major Business
Table 102. Johnson & Johnson Recombinant Glycoproteins Product and Services
Table 103. Johnson & Johnson Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Johnson & Johnson Recent Developments/Updates
Table 105. Johnson & Johnson Competitive Strengths & Weaknesses
Table 106. Merck Basic Information, Manufacturing Base and Competitors
Table 107. Merck Major Business
Table 108. Merck Recombinant Glycoproteins Product and Services
Table 109. Merck Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Merck Recent Developments/Updates
Table 111. Merck Competitive Strengths & Weaknesses
Table 112. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 113. AstraZeneca Major Business
Table 114. AstraZeneca Recombinant Glycoproteins Product and Services
Table 115. AstraZeneca Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. AstraZeneca Recent Developments/Updates
Table 117. AstraZeneca Competitive Strengths & Weaknesses
Table 118. Sanofi Basic Information, Manufacturing Base and Competitors
Table 119. Sanofi Major Business
Table 120. Sanofi Recombinant Glycoproteins Product and Services
Table 121. Sanofi Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Sanofi Recent Developments/Updates
Table 123. Sanofi Competitive Strengths & Weaknesses
Table 124. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 125. Bristol Myers Squibb Major Business
Table 126. Bristol Myers Squibb Recombinant Glycoproteins Product and Services
Table 127. Bristol Myers Squibb Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Bristol Myers Squibb Recent Developments/Updates
Table 129. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 130. Amgen Basic Information, Manufacturing Base and Competitors
Table 131. Amgen Major Business
Table 132. Amgen Recombinant Glycoproteins Product and Services
Table 133. Amgen Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Amgen Recent Developments/Updates
Table 135. Amgen Competitive Strengths & Weaknesses
Table 136. Regeneron Basic Information, Manufacturing Base and Competitors
Table 137. Regeneron Major Business
Table 138. Regeneron Recombinant Glycoproteins Product and Services
Table 139. Regeneron Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Regeneron Recent Developments/Updates
Table 141. Regeneron Competitive Strengths & Weaknesses
Table 142. Sandoz Basic Information, Manufacturing Base and Competitors
Table 143. Sandoz Major Business
Table 144. Sandoz Recombinant Glycoproteins Product and Services
Table 145. Sandoz Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Sandoz Recent Developments/Updates
Table 147. Sandoz Competitive Strengths & Weaknesses
Table 148. Teva Basic Information, Manufacturing Base and Competitors
Table 149. Teva Major Business
Table 150. Teva Recombinant Glycoproteins Product and Services
Table 151. Teva Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 152. Teva Recent Developments/Updates
Table 153. Teva Competitive Strengths & Weaknesses
Table 154. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 155. Fresenius Kabi Major Business
Table 156. Fresenius Kabi Recombinant Glycoproteins Product and Services
Table 157. Fresenius Kabi Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 158. Fresenius Kabi Recent Developments/Updates
Table 159. Fresenius Kabi Competitive Strengths & Weaknesses
Table 160. STADA Basic Information, Manufacturing Base and Competitors
Table 161. STADA Major Business
Table 162. STADA Recombinant Glycoproteins Product and Services
Table 163. STADA Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 164. STADA Recent Developments/Updates
Table 165. STADA Competitive Strengths & Weaknesses
Table 166. Biogen Basic Information, Manufacturing Base and Competitors
Table 167. Biogen Major Business
Table 168. Biogen Recombinant Glycoproteins Product and Services
Table 169. Biogen Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Biogen Recent Developments/Updates
Table 171. Biogen Competitive Strengths & Weaknesses
Table 172. Celltrion Basic Information, Manufacturing Base and Competitors
Table 173. Celltrion Major Business
Table 174. Celltrion Recombinant Glycoproteins Product and Services
Table 175. Celltrion Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 176. Celltrion Recent Developments/Updates
Table 177. Celltrion Competitive Strengths & Weaknesses
Table 178. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 179. Samsung Bioepis Major Business
Table 180. Samsung Bioepis Recombinant Glycoproteins Product and Services
Table 181. Samsung Bioepis Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 182. Samsung Bioepis Recent Developments/Updates
Table 183. Samsung Bioepis Competitive Strengths & Weaknesses
Table 184. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 185. Samsung Biologics Major Business
Table 186. Samsung Biologics Recombinant Glycoproteins Product and Services
Table 187. Samsung Biologics Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 188. Samsung Biologics Recent Developments/Updates
Table 189. Samsung Biologics Competitive Strengths & Weaknesses
Table 190. Biocon Basic Information, Manufacturing Base and Competitors
Table 191. Biocon Major Business
Table 192. Biocon Recombinant Glycoproteins Product and Services
Table 193. Biocon Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 194. Biocon Recent Developments/Updates
Table 195. Biocon Competitive Strengths & Weaknesses
Table 196. Intas Basic Information, Manufacturing Base and Competitors
Table 197. Intas Major Business
Table 198. Intas Recombinant Glycoproteins Product and Services
Table 199. Intas Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Intas Recent Developments/Updates
Table 201. Intas Competitive Strengths & Weaknesses
Table 202. Dr. Reddy?s Basic Information, Manufacturing Base and Competitors
Table 203. Dr. Reddy?s Major Business
Table 204. Dr. Reddy?s Recombinant Glycoproteins Product and Services
Table 205. Dr. Reddy?s Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 206. Dr. Reddy?s Recent Developments/Updates
Table 207. Dr. Reddy?s Competitive Strengths & Weaknesses
Table 208. Apotex Basic Information, Manufacturing Base and Competitors
Table 209. Apotex Major Business
Table 210. Apotex Recombinant Glycoproteins Product and Services
Table 211. Apotex Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 212. Apotex Recent Developments/Updates
Table 213. Apotex Competitive Strengths & Weaknesses
Table 214. Alvotech Basic Information, Manufacturing Base and Competitors
Table 215. Alvotech Major Business
Table 216. Alvotech Recombinant Glycoproteins Product and Services
Table 217. Alvotech Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 218. Alvotech Recent Developments/Updates
Table 219. Alvotech Competitive Strengths & Weaknesses
Table 220. Coherus Basic Information, Manufacturing Base and Competitors
Table 221. Coherus Major Business
Table 222. Coherus Recombinant Glycoproteins Product and Services
Table 223. Coherus Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 224. Coherus Recent Developments/Updates
Table 225. Coherus Competitive Strengths & Weaknesses
Table 226. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 227. Boehringer Ingelheim Major Business
Table 228. Boehringer Ingelheim Recombinant Glycoproteins Product and Services
Table 229. Boehringer Ingelheim Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 230. Boehringer Ingelheim Recent Developments/Updates
Table 231. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 232. Lonza Basic Information, Manufacturing Base and Competitors
Table 233. Lonza Major Business
Table 234. Lonza Recombinant Glycoproteins Product and Services
Table 235. Lonza Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 236. Lonza Recent Developments/Updates
Table 237. Lonza Competitive Strengths & Weaknesses
Table 238. FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 239. FUJIFILM Diosynth Biotechnologies Major Business
Table 240. FUJIFILM Diosynth Biotechnologies Recombinant Glycoproteins Product and Services
Table 241. FUJIFILM Diosynth Biotechnologies Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 242. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 243. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 244. WuXi Biologics Basic Information, Manufacturing Base and Competitors
Table 245. WuXi Biologics Major Business
Table 246. WuXi Biologics Recombinant Glycoproteins Product and Services
Table 247. WuXi Biologics Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 248. WuXi Biologics Recent Developments/Updates
Table 249. WuXi Biologics Competitive Strengths & Weaknesses
Table 250. Bio-Thera Solutions Basic Information, Manufacturing Base and Competitors
Table 251. Bio-Thera Solutions Major Business
Table 252. Bio-Thera Solutions Recombinant Glycoproteins Product and Services
Table 253. Bio-Thera Solutions Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 254. Bio-Thera Solutions Recent Developments/Updates
Table 255. Bio-Thera Solutions Competitive Strengths & Weaknesses
Table 256. Henlius Basic Information, Manufacturing Base and Competitors
Table 257. Henlius Major Business
Table 258. Henlius Recombinant Glycoproteins Product and Services
Table 259. Henlius Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 260. Henlius Recent Developments/Updates
Table 261. Henlius Competitive Strengths & Weaknesses
Table 262. Innovent Biologics Basic Information, Manufacturing Base and Competitors
Table 263. Innovent Biologics Major Business
Table 264. Innovent Biologics Recombinant Glycoproteins Product and Services
Table 265. Innovent Biologics Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 266. Innovent Biologics Recent Developments/Updates
Table 267. Innovent Biologics Competitive Strengths & Weaknesses
Table 268. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 269. Hengrui Pharmaceutical Major Business
Table 270. Hengrui Pharmaceutical Recombinant Glycoproteins Product and Services
Table 271. Hengrui Pharmaceutical Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 272. Hengrui Pharmaceutical Recent Developments/Updates
Table 273. Hengrui Pharmaceutical Competitive Strengths & Weaknesses
Table 274. Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 275. Junshi Biosciences Major Business
Table 276. Junshi Biosciences Recombinant Glycoproteins Product and Services
Table 277. Junshi Biosciences Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 278. Junshi Biosciences Recent Developments/Updates
Table 279. Junshi Biosciences Competitive Strengths & Weaknesses
Table 280. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 281. Sino Biological Major Business
Table 282. Sino Biological Recombinant Glycoproteins Product and Services
Table 283. Sino Biological Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 284. Sino Biological Recent Developments/Updates
Table 285. Sino Biological Competitive Strengths & Weaknesses
Table 286. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 287. ACROBiosystems Major Business
Table 288. ACROBiosystems Recombinant Glycoproteins Product and Services
Table 289. ACROBiosystems Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 290. ACROBiosystems Recent Developments/Updates
Table 291. ACROBiosystems Competitive Strengths & Weaknesses
Table 292. GenScript Basic Information, Manufacturing Base and Competitors
Table 293. GenScript Major Business
Table 294. GenScript Recombinant Glycoproteins Product and Services
Table 295. GenScript Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 296. GenScript Recent Developments/Updates
Table 297. GenScript Competitive Strengths & Weaknesses
Table 298. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 299. Bio-Techne Major Business
Table 300. Bio-Techne Recombinant Glycoproteins Product and Services
Table 301. Bio-Techne Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 302. Bio-Techne Recent Developments/Updates
Table 303. Bio-Techne Competitive Strengths & Weaknesses
Table 304. Takeda Basic Information, Manufacturing Base and Competitors
Table 305. Takeda Major Business
Table 306. Takeda Recombinant Glycoproteins Product and Services
Table 307. Takeda Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 308. Takeda Recent Developments/Updates
Table 309. Takeda Competitive Strengths & Weaknesses
Table 310. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table 311. Kyowa Kirin Major Business
Table 312. Kyowa Kirin Recombinant Glycoproteins Product and Services
Table 313. Kyowa Kirin Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 314. Kyowa Kirin Recent Developments/Updates
Table 315. Kyowa Kirin Competitive Strengths & Weaknesses
Table 316. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 317. Daiichi Sankyo Major Business
Table 318. Daiichi Sankyo Recombinant Glycoproteins Product and Services
Table 319. Daiichi Sankyo Recombinant Glycoproteins Production (MT), Price (USD/MT), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 320. Daiichi Sankyo Recent Developments/Updates
Table 321. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 322. Global Key Players of Recombinant Glycoproteins Upstream (Raw Materials)
Table 323. Global Recombinant Glycoproteins Typical Customers
Table 324. Recombinant Glycoproteins Typical Distributors
LIST OF FIGURES
Figure 1. Recombinant Glycoproteins Picture
Figure 2. World Recombinant Glycoproteins Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Recombinant Glycoproteins Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 5. World Recombinant Glycoproteins Average Price (2021-2032) & (USD/MT)
Figure 6. World Recombinant Glycoproteins Production Value Market Share by Region (2021-2032)
Figure 7. World Recombinant Glycoproteins Production Market Share by Region (2021-2032)
Figure 8. North America Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 9. Europe Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 10. China Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 11. Japan Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 12. South Korea Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 13. India Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 14. Recombinant Glycoproteins Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 17. World Recombinant Glycoproteins Consumption Market Share by Region (2021-2032)
Figure 18. United States Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 19. China Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 20. Europe Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 21. Japan Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 22. South Korea Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 23. ASEAN Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 24. India Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 25. Producer Shipments of Recombinant Glycoproteins by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Recombinant Glycoproteins Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Recombinant Glycoproteins Markets in 2025
Figure 28. United States VS China: Recombinant Glycoproteins Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Recombinant Glycoproteins Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Recombinant Glycoproteins Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Recombinant Glycoproteins Production Market Share 2025
Figure 32. China Based Manufacturers Recombinant Glycoproteins Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Recombinant Glycoproteins Production Market Share 2025
Figure 34. World Recombinant Glycoproteins Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Recombinant Glycoproteins Production Value Market Share by Type in 2025
Figure 36. Monoclonal Antibodies
Figure 37. Fc Fusion Proteins
Figure 38. Glycoprotein Hormones
Figure 39. Enzyme Replacement Proteins
Figure 40. Viral Glycoproteins
Figure 41. Others
Figure 42. World Recombinant Glycoproteins Production Market Share by Type (2021-2032)
Figure 43. World Recombinant Glycoproteins Production Value Market Share by Type (2021-2032)
Figure 44. World Recombinant Glycoproteins Average Price by Type (2021-2032) & (USD/MT)
Figure 45. World Recombinant Glycoproteins Production Value by Expression System, (USD Million), 2021 & 2025 & 2032
Figure 46. World Recombinant Glycoproteins Production Value Market Share by Expression System in 2025
Figure 47. Mammalian Cell Expression
Figure 48. Yeast Expression
Figure 49. Insect Cell Expression
Figure 50. Others
Figure 51. World Recombinant Glycoproteins Production Market Share by Expression System (2021-2032)
Figure 52. World Recombinant Glycoproteins Production Value Market Share by Expression System (2021-2032)
Figure 53. World Recombinant Glycoproteins Average Price by Expression System (2021-2032) & (USD/MT)
Figure 54. World Recombinant Glycoproteins Production Value by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 55. World Recombinant Glycoproteins Production Value Market Share by Product Form in 2025
Figure 56. Lyophilized Powder
Figure 57. Liquid Solution
Figure 58. Frozen Bulk Protein
Figure 59. Formulated Drug Product
Figure 60. World Recombinant Glycoproteins Production Market Share by Product Form (2021-2032)
Figure 61. World Recombinant Glycoproteins Production Value Market Share by Product Form (2021-2032)
Figure 62. World Recombinant Glycoproteins Average Price by Product Form (2021-2032) & (USD/MT)
Figure 63. World Recombinant Glycoproteins Production Value by Glycosylation Type, (USD Million), 2021 & 2025 & 2032
Figure 64. World Recombinant Glycoproteins Production Value Market Share by Glycosylation Type in 2025
Figure 65. N-Linked Glycoproteins
Figure 66. O-Linked Glycoproteins
Figure 67. Mixed N- and O-Linked Glycoproteins
Figure 68. World Recombinant Glycoproteins Production Market Share by Glycosylation Type (2021-2032)
Figure 69. World Recombinant Glycoproteins Production Value Market Share by Glycosylation Type (2021-2032)
Figure 70. World Recombinant Glycoproteins Average Price by Glycosylation Type (2021-2032) & (USD/MT)
Figure 71. World Recombinant Glycoproteins Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 72. World Recombinant Glycoproteins Production Value Market Share by Application in 2025
Figure 73. Blood & Oncology Diseases
Figure 74. Chronic Diseases
Figure 75. Others
Figure 76. World Recombinant Glycoproteins Production Market Share by Application (2021-2032)
Figure 77. World Recombinant Glycoproteins Production Value Market Share by Application (2021-2032)
Figure 78. World Recombinant Glycoproteins Average Price by Application (2021-2032) & (USD/MT)
Figure 79. Recombinant Glycoproteins Industry Chain
Figure 80. Recombinant Glycoproteins Procurement Model
Figure 81. Recombinant Glycoproteins Sales Model
Figure 82. Recombinant Glycoproteins Sales Channels, Direct Sales, and Distribution
Figur
Figure 1. Recombinant Glycoproteins Picture
Figure 2. World Recombinant Glycoproteins Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Recombinant Glycoproteins Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 5. World Recombinant Glycoproteins Average Price (2021-2032) & (USD/MT)
Figure 6. World Recombinant Glycoproteins Production Value Market Share by Region (2021-2032)
Figure 7. World Recombinant Glycoproteins Production Market Share by Region (2021-2032)
Figure 8. North America Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 9. Europe Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 10. China Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 11. Japan Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 12. South Korea Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 13. India Recombinant Glycoproteins Production (2021-2032) & (MT)
Figure 14. Recombinant Glycoproteins Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 17. World Recombinant Glycoproteins Consumption Market Share by Region (2021-2032)
Figure 18. United States Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 19. China Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 20. Europe Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 21. Japan Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 22. South Korea Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 23. ASEAN Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 24. India Recombinant Glycoproteins Consumption (2021-2032) & (MT)
Figure 25. Producer Shipments of Recombinant Glycoproteins by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Recombinant Glycoproteins Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Recombinant Glycoproteins Markets in 2025
Figure 28. United States VS China: Recombinant Glycoproteins Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Recombinant Glycoproteins Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Recombinant Glycoproteins Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Recombinant Glycoproteins Production Market Share 2025
Figure 32. China Based Manufacturers Recombinant Glycoproteins Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Recombinant Glycoproteins Production Market Share 2025
Figure 34. World Recombinant Glycoproteins Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Recombinant Glycoproteins Production Value Market Share by Type in 2025
Figure 36. Monoclonal Antibodies
Figure 37. Fc Fusion Proteins
Figure 38. Glycoprotein Hormones
Figure 39. Enzyme Replacement Proteins
Figure 40. Viral Glycoproteins
Figure 41. Others
Figure 42. World Recombinant Glycoproteins Production Market Share by Type (2021-2032)
Figure 43. World Recombinant Glycoproteins Production Value Market Share by Type (2021-2032)
Figure 44. World Recombinant Glycoproteins Average Price by Type (2021-2032) & (USD/MT)
Figure 45. World Recombinant Glycoproteins Production Value by Expression System, (USD Million), 2021 & 2025 & 2032
Figure 46. World Recombinant Glycoproteins Production Value Market Share by Expression System in 2025
Figure 47. Mammalian Cell Expression
Figure 48. Yeast Expression
Figure 49. Insect Cell Expression
Figure 50. Others
Figure 51. World Recombinant Glycoproteins Production Market Share by Expression System (2021-2032)
Figure 52. World Recombinant Glycoproteins Production Value Market Share by Expression System (2021-2032)
Figure 53. World Recombinant Glycoproteins Average Price by Expression System (2021-2032) & (USD/MT)
Figure 54. World Recombinant Glycoproteins Production Value by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 55. World Recombinant Glycoproteins Production Value Market Share by Product Form in 2025
Figure 56. Lyophilized Powder
Figure 57. Liquid Solution
Figure 58. Frozen Bulk Protein
Figure 59. Formulated Drug Product
Figure 60. World Recombinant Glycoproteins Production Market Share by Product Form (2021-2032)
Figure 61. World Recombinant Glycoproteins Production Value Market Share by Product Form (2021-2032)
Figure 62. World Recombinant Glycoproteins Average Price by Product Form (2021-2032) & (USD/MT)
Figure 63. World Recombinant Glycoproteins Production Value by Glycosylation Type, (USD Million), 2021 & 2025 & 2032
Figure 64. World Recombinant Glycoproteins Production Value Market Share by Glycosylation Type in 2025
Figure 65. N-Linked Glycoproteins
Figure 66. O-Linked Glycoproteins
Figure 67. Mixed N- and O-Linked Glycoproteins
Figure 68. World Recombinant Glycoproteins Production Market Share by Glycosylation Type (2021-2032)
Figure 69. World Recombinant Glycoproteins Production Value Market Share by Glycosylation Type (2021-2032)
Figure 70. World Recombinant Glycoproteins Average Price by Glycosylation Type (2021-2032) & (USD/MT)
Figure 71. World Recombinant Glycoproteins Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 72. World Recombinant Glycoproteins Production Value Market Share by Application in 2025
Figure 73. Blood & Oncology Diseases
Figure 74. Chronic Diseases
Figure 75. Others
Figure 76. World Recombinant Glycoproteins Production Market Share by Application (2021-2032)
Figure 77. World Recombinant Glycoproteins Production Value Market Share by Application (2021-2032)
Figure 78. World Recombinant Glycoproteins Average Price by Application (2021-2032) & (USD/MT)
Figure 79. Recombinant Glycoproteins Industry Chain
Figure 80. Recombinant Glycoproteins Procurement Model
Figure 81. Recombinant Glycoproteins Sales Model
Figure 82. Recombinant Glycoproteins Sales Channels, Direct Sales, and Distribution
Figur
